Chemoinformaics analysis of Archangelicin-Diester
| Molecular Weight | 426.465 | nRot | 5 |
| Heavy Atom Molecular Weight | 400.257 | nRig | 20 |
| Exact Molecular Weight | 426.168 | nRing | 3 |
| Solubility: LogS | -3.877 | nHRing | 2 |
| Solubility: LogP | 3.755 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 11 |
| nHA | 7 | APOL | 63.0306 |
| nHD | 0 | BPOL | 35.6314 |
| QED | 0.398 |
| Synth | 4.067 |
| Natural Product Likeliness | 1.986 |
| NR-PPAR-gamma | 0.087 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.019 |
| CACO-2 | -4.755 |
| MDCK | 0.0000215 |
| BBB | 0.012 |
| PPB | 0.815147 |
| VDSS | 1.884 |
| FU | 0.072497 |
| CYP1A2-inh | 0.238 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.9 |
| CYP2c19-sub | 0.265 |
| CYP2c9-inh | 0.912 |
| CYP2c9-sub | 0.19 |
| CYP2d6-inh | 0.896 |
| CYP2d6-sub | 0.236 |
| CYP3a4-inh | 0.933 |
| CYP3a4-sub | 0.617 |
| CL | 6.292 |
| T12 | 0.606 |
| hERG | 0.011 |
| Ames | 0.085 |
| ROA | 0.101 |
| SkinSen | 0.307 |
| Carcinogencity | 0.528 |
| EI | 0.023 |
| Respiratory | 0.146 |
| NR-Aromatase | 0.942 |
| Antiviral | Yes |
| Prediction | 0.830991 |